| Date | Ticker | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 1, 2026 | Pharvaris N.V. | Lesage Anne Chief Early Development | sell | 3,700 | $30.26 | $112K |
| May 1, 2026 | Pharvaris N.V. | Lesage Anne Chief Early Development | sell | 18,000 | $30.26 | $545K |
| May 1, 2026 | CoreWeave, Inc. | Baker Jeff Principal Accounting Officer | sell | 6,760 | $107.87 | $729K |
| May 1, 2026 | Delek US Holdings, Inc. | Yemin Ezra Uzi | sell | 7,633 | $46.07 | $352K |
| May 1, 2026 | Delek US Holdings, Inc. | Yemin Ezra Uzi | sell | 9,367 | $46.91 | $439K |
| May 1, 2026 | CRWD👔 CrowdStrike Holdings, Inc. | Kurtz George PRESIDENT AND CEO | sell | 323 | $447.69 | $145K |
| May 1, 2026 | CRWD👔 CrowdStrike Holdings, Inc. | Kurtz George PRESIDENT AND CEO | sell | 583 | $448.69 | $262K |
| May 1, 2026 | CRWD👔 CrowdStrike Holdings, Inc. | Kurtz George PRESIDENT AND CEO | sell | 615 | $449.71 | $277K |
| May 1, 2026 | CRWD👔 CrowdStrike Holdings, Inc. | Kurtz George PRESIDENT AND CEO | sell | 312 | $450.72 | $141K |
| May 1, 2026 | CRWD👔 CrowdStrike Holdings, Inc. | Kurtz George PRESIDENT AND CEO | sell | 550 | $451.78 | $248K |
| May 1, 2026 | Merck & Co Inc | Oosthuizen Johannes Jacobus | sell | 679 | $110.03 | $75K |
| May 1, 2026 | CRWD👔 CrowdStrike Holdings, Inc. | Kurtz George PRESIDENT AND CEO | sell | 559 | $444.33 | $248K |
| May 1, 2026 | CRWD👔 CrowdStrike Holdings, Inc. | Kurtz George PRESIDENT AND CEO | sell | 468 | $445.33 | $208K |
| May 1, 2026 | CRWD👔 CrowdStrike Holdings, Inc. | Kurtz George PRESIDENT AND CEO | sell | 251 | $446.23 | $112K |
| May 1, 2026 | INDI👔 indie Semiconductor, Inc. | Aoki Ichiro President | sell | 100,000 | $4.40 | $440K |
| May 1, 2026 | Alkermes plc. | Hopkinson Craig C. EVP R&D, Chief Medical Officer | sell | 9,000 | $33.40 | $301K |
| May 1, 2026 | CCB👔 COASTAL FINANCIAL CORP | Hamilton Brian T President of CCBX | sell | 3,079 | $75.44 | $232K |
| May 1, 2026 | Spyre Therapeutics, Inc. | Sloan Sheldon Chief Medical Officer | sell | 21,306 | $69.53 | $1.48M$1M+ |
| May 1, 2026 | Spyre Therapeutics, Inc. | Sloan Sheldon Chief Medical Officer | sell | 19,656 | $70.61 | $1.39M$1M+ |
| May 1, 2026 | Spyre Therapeutics, Inc. | Sloan Sheldon Chief Medical Officer | sell | 8,777 | $71.56 | $628K |